Phase 3 Glaucoma, Open-Angle trials recruiting now

All Glaucoma, Open-Angle trials, every phase

Phase 3 Glaucoma, Open-Angle trials

• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
  NCT05401357 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma
  NCT05710198 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial
  NCT05405868 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.